Berg, Anna Korsgaard http://orcid.org/0000-0002-1260-0615
Svensson, Jannet http://orcid.org/0000-0002-9365-0728
Thyssen, Jacob P. http://orcid.org/0000-0003-3770-1743
Chawes, Bo http://orcid.org/0000-0001-6846-6243
Zachariae, Claus http://orcid.org/0000-0001-5506-1319
Egeberg, Alexander http://orcid.org/0000-0001-8257-1816
Thorsen, Steffen Ullitz http://orcid.org/0000-0003-4783-2931
Funding for this research was provided by:
Novo Nordisk Fonden (NNF17SA0031406)
Pfizer
Regeneron
Sanofi-Genzyme
Eli Lilly
Novartis
Bristol-Myers Squibb
AbbVie
Janssen Pharmaceuticals
Boehringer Ingelheim
Danish National Psoriasis Foundation
Simon Spies Foundation
Kongelig Hofbuntmager Aage Bangs Fond
Article History
Received: 7 February 2023
Accepted: 11 November 2023
First Online: 15 November 2023
Competing interests
: A.K.B, J.S, B.C, C.Z and S.U.T. declare no competing interests for this manuscript. J.P.T is an advisor for AbbVie, Almirall, Arena Pharmaceuticals, Coloplast, OM Pharma, Aslan Phar-maceuticals, Union Therapeutics, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sanofi-Genzyme, a speaker for AbbVie, Almirall, Eli Lilly & Co, LEO Pharma, Pfizer, Regeneron, and Sano-fi-Genzyme, and received research grants from Pfizer, Regeneron, and Sanofi-Genzyme. A.E has received research funding from Pfizer, Eli Lilly, Novartis, Bristol-Myers Squibb, AbbVie, Janssen Pharmaceuticals, Boehringer Ingelheim, the Danish National Psoriasis Foundation, the Simon Spies Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and honoraria as consultant and/or speaker from Amgen, AbbVie, Almirall, Leo Pharma, Zuellig Pharma Ltd., Galápagos NV, Sun Pharmaceuticals, Samsung Bioepis Co., Ltd., Pfizer, Eli Lilly and Company, Novartis, Union Thera-peutics, Galderma, Dermavant, UCB, Mylan, Bristol-Myers Squibb, McNeil Consumer Healthcare, Horizon Therapeutics, Boehringer Ingelheim, and Janssen Pharmaceuticals.